Significantly inhibitory effects of low molecular weight heparin (Fraxiparine) on the motility of lung cancer cells and its related mechanism

PP242 suppresses cell proliferation, metastasis, and angiogenesis of gastric cancer through inhibition of the PI3K/AKT/mTOR pathway

(2014) Xiaofang Xing et al.   ANTI-CANCER DRUGS

EBP50 inhibits the migration and invasion of human breast cancer cells via LIMK/cofilin and the PI3K/Akt/mTOR/MMP signaling pathway

(2014) Hongli Li et al.   MEDICAL ONCOLOGY

FTY720 reduces migration and invasion of human glioblastoma cell lines via inhibiting the PI3K/AKT/mTOR/p70S6K signaling pathway

(2014) Li Zhang et al.   TUMOR BIOLOGY

The mechanisms of nadroparin-mediated inhibition of proliferation of two human lung cancer cell lines

(2012) Y. Carmazzi et al.   CELL PROLIFERATION

Fucoidan from Seaweed Fucus vesiculosus Inhibits Migration and Invasion of Human Lung Cancer Cell via PI3K-Akt-mTOR Pathways

(2012) Hyunkyoung Lee et al.   PLoS One

Downregulation of Akt and FAK phosphorylation reduces invasion of glioblastoma cells by impairment of MT1-MMP shuttling to lamellipodia and downregulates MMPs expression

(2011) Aneta Kwiatkowska et al.   BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH

Concentration- and time-dependent effects of enoxaparin on human adenocarcinomic epithelial cell line A549 proliferation in vitro

(2011) Walid Abu Arab et al.   CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY

Low molecular weight heparin inhibits melanoma cell adhesion and migration through a PKCa/JNK signaling pathway inducing actin cytoskeleton changes

(2011) Georgia Chalkiadaki et al.   CANCER LETTERS

Targeting phosphoinositide 3-kinase signalling in lung cancer

(2011) Anna Wojtalla et al.   CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY

CXC receptor-4 mRNA silencing abrogates CXCL12-induced migration of colorectal cancer cells

(2011) Claudia Rubie et al.   Journal of Translational Medicine

Effet de la tinzaparine sur la mortalité du cancer bronchique non à petites cellules opéré

(2011) G. Meyer et al.   REVUE DES MALADIES RESPIRATOIRES

The role of chemokine receptor CXCR4 in lung cancer

(2010) Tara Gangadhar et al.   CANCER BIOLOGY & THERAPY

CXCL12 (SDF-1)/CXCR4 Pathway in Cancer

(2010) B. A. Teicher et al.   CLINICAL CANCER RESEARCH

Antitumor Effect of Butanoylated Heparin with Low Anticoagulant Activity on Lung Cancer Growth in Mice and Rats

(2010) Lunyin Yu et al.   CURRENT CANCER DRUG TARGETS

Inhibitory effects of andrographolide on migration and invasion in human non-small cell lung cancer A549 cells via down-regulation of PI3K/Akt signaling pathway

(2010) Yi-Chieh Lee et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Modulating the interaction of CXCR4 and CXCL12 by low-molecular-weight heparin inhibits hepatic metastasis of colon cancer

(2010) Lixin Ma et al.   INVESTIGATIONAL NEW DRUGS

High antiangiogenic and low anticoagulant efficacy of orally active low molecular weight heparin derivatives

(2010) Jin Woo Park et al.   JOURNAL OF CONTROLLED RELEASE

Class IA Phosphatidylinositol 3-Kinase Signaling in Non-small Cell Lung Cancer

(2010) Benjamin Solomon et al.   Journal of Thoracic Oncology

Early Palliative Care for Patients with Metastatic Non–Small-Cell Lung Cancer

(2010) Jennifer S. Temel et al.   NEW ENGLAND JOURNAL OF MEDICINE

Isoform-selective phosphoinositide 3'-kinase inhibitors inhibit CXCR4 signaling and overcome stromal cell-mediated drug resistance in chronic lymphocytic leukemia: a novel therapeutic approach

(2009) M. Niedermeier et al.   BLOOD

FRAGMATIC: A randomised phase III clinical trial investigating the effect of fragmin® added to standard therapy in patients with lung cancer

(2009) Gareth O Griffiths et al.   BMC CANCER

EMT, the cytoskeleton, and cancer cell invasion

(2009) Mahmut Yilmaz et al.   CANCER AND METASTASIS REVIEWS

The Effect of LMWH (Nadroparin) on Tumor Progression

(2009) Zsuzsanna Nagy et al.   PATHOLOGY & ONCOLOGY RESEARCH

The Effect of Dalteparin, a Kind of Low Molecular Weight Heparin, on Lung Adenocarcinoma A549 Cell LineIn Vitro

(2008) Xiaojun Chen et al.   CANCER INVESTIGATION

A Novel Lung Cancer Signature Mediates Metastatic Bone Colonization by a Dual Mechanism

(2008) S. Vicent et al.   CANCER RESEARCH